Arch Biopartners's total assets for Q3 2025 were C$266.46K, a decrease of -51.52% from the previous quarter. TSE:ARCH total liabilities were C$3.92M for the fiscal quarter, a -9.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.